Arch Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 10,973 | 0.231% |
| Hedge Funds | 300,000 | 6.32% |
| Institutions | 600,000 | 12.6% |
| VC/PE Firms | 600,000 | 12.6% |
| Individual Insiders | 900,138 | 19% |
| General Public | 2,333,252 | 49.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 276.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 300,000 | US$939.0k | 0% | no data | |||
| 300,000 | US$939.0k | 0% | no data | |||
| 300,000 | US$939.0k | 0% | 0.01% | |||
| 300,000 | US$939.0k | 0% | no data | |||
| 300,000 | US$939.0k | 0% | 100.0% | |||
| 300,000 | US$939.0k | 0% | 52.34% | |||
| 205,124 | US$642.0k | -12.9% | no data | |||
| 150,000 | US$469.5k | 0% | 5.53% | |||
| 150,000 | US$469.5k | 0% | 7.17% | |||
| 75,023 | US$234.8k | 10.1% | no data | |||
| 10,973 | US$34.3k | 1,510% | no data | |||
| 10,836 | US$33.9k | 1,890% | no data | |||
| 8,405 | US$26.3k | -87% | no data | |||
| 750 | US$2.3k | 0% | no data |